Search Results | Diabetes | American Diabetes Association

1-20 of 141

2 3 4 5

Sort by

Sort Order Select

Meeting Abstracts

404-P: Relationships among Triglyceride (TG) Concentrations across Lipoprotein Subclasses, Intraglomerular Hemodynamics, and Kidney Oxygen Availability in Adolescents with Type 1 Diabetes (T1D)

MEGHAN E. PAULEY, KALIE L. TOMMERDAHL, CARISSA VINOVSKIS, LAURA PYLE, R. PAUL WADWA, ROBERT G. NELSON, KRISTEN J. NADEAU, PETTER BJORNSTAD

Diabetes 2022;71(Supplement_1):404-P

DOI: https://doi.org/10.2337/db22-404-P

Published: 01 June 2022

View article

Meeting Abstracts

1092-P: Lipoprotein Insulin Resistance Index and Mortality in Heart Failure: A Population Study

SARAH TURECAMO, ANNA WOLSKA, JAMES D. OTVOS, ALAN REMALEY, KATIE CONNERS, JUNGNAM JOO, HO YOUNG PARK, MAUREEN SAMPSON, SUZETTE J. BIELINSKI, JENNIFER ST SAUVER, VERONIQUE L. ROGER

Diabetes 2022;71(Supplement_1):1092-P

DOI: https://doi.org/10.2337/db22-1092-P

Published: 01 June 2022

View article

Meeting Abstracts

1118-P: Prediction of Clamp-Derived Insulin Sensitivity in African Americans from Clinical Risk Factors

LAUREN A. FOWLER, VIBHU PARCHA, CATHARINE COUCH, W. TIMOTHY GARVEY, BARBARA GOWER

Diabetes 2022;71(Supplement_1):1118-P

DOI: https://doi.org/10.2337/db22-1118-P

Published: 01 June 2022

View article

Meeting Abstracts

893-P: Triglyceride-Rich Remnant Lipoproteins, Insulin Resistance, and Subclinical Inflammation in Youth with Type 2 Diabetes

ALFREDO VILLALOBOS-PEREZ, ANNA ZENNO, CELESTE K. CRAVALHO, SAMANTHA MATTA, AMBER B. COURVILLE, LILIAN MABUNDO, VANDHNA R. SHARMA, JOSHUA M. DAWSON, MOREY W. HAYMOND, STEPHANIE T. CHUNG

Diabetes 2021;70(Supplement_1):893-P

DOI: https://doi.org/10.2337/db21-893-P

Published: 01 June 2021

View article

Meeting Abstracts

381-P: Type 2 Diabetes Significantly Modulates the Power of Lipoprotein(a) to Predict Cardiovascular Events and Mortality in Young Coronary Artery Disease Patients

ARTHUR MADER, MAXIMILIAN MAECHLER, BARBARA LARCHER, LUKAS SPRENGER, BEATRIX MUTSCHLECHNER, ANDREAS LEIHERER, AXEL MUENDLEIN, ALEXANDER VONBANK, HEINZ DREXEL, CHRISTOPH H. SAELY

Diabetes 2021;70(Supplement_1):381-P

DOI: https://doi.org/10.2337/db21-381-P

Published: 01 June 2021

View article

Meeting Abstracts

300-OR: Association of Raised Lipoprotein(a) Levels with Micro- and Macrovascular Complications in Patients with Type 1 Diabetes

SOPHIE VAN HAARE HEIJMEIJER, MICHEL P. HERMANS

Diabetes 2021;70(Supplement_1):300-OR

DOI: https://doi.org/10.2337/db21-300-OR

Published: 01 June 2021

View article

Journal Articles

Simultaneous Inhibition of Peripheral CB1R and iNOS Mitigates Obesity-Related Dyslipidemia Through Distinct Mechanisms

Célia Roger, Chloé Buch, Tania Muller, Julia Leemput, Laurent Demizieux, Patricia Passilly-Degrace, Resat Cinar, Malliga R. Iyer, George Kunos, Bruno Vergès, Pascal Degrace, Tony Jourdan

Diabetes 2020;69(10):2120–2132

DOI: https://doi.org/10.2337/db20-0078

Published: 17 July 2020

View article

Meeting Abstracts

169-OR: Differential Effects of Amount, Intensity, and Mode of Exercise Training on the Diabetes Risk Index

LEANNA M. ROSS, CRIS A. SLENTZ, IRINA Y. SHALAUROVA, JAMES D. OTVOS, MARGERY A. CONNELLY, CONNIE W. BALES, JOSEPH A. HOUMARD, WILLIAM E. KRAUS

Diabetes 2020;69(Supplement_1):169-OR

DOI: https://doi.org/10.2337/db20-169-OR

Published: 01 June 2020

View article

Meeting Abstracts

37-LB: GLP-2 Regulation of Dietary Fat Absorption and Intestinal Lipoprotein Production: The Role of the Enteric Nervous System via nNOS Signaling

ELISABETH M. GRANDE, KHOSROW ADELI

Diabetes 2020;69(Supplement_1):37-LB

DOI: https://doi.org/10.2337/db20-37-LB

Published: 01 June 2020

View article

Meeting Abstracts

1480-P: Increased Particle Size of Triglyceride Remnant Lipoproteins, but Not Plasma Concentration or Lipid Content, Boost Risk Prediction of Incident Type 2 Diabetes

LUIZ SERGIO F. CARVALHO, ISABELA M. BENSENOR, PAULO A. LOTUFO, ANDREI C. SPOSITO

Diabetes 2020;69(Supplement_1):1480-P

DOI: https://doi.org/10.2337/db20-1480-P

Published: 01 June 2020

View article

Meeting Abstracts

412-P: Lipoprotein(a) and Vascular Risk in Patients with Established Cardiovascular Disease

CHRISTOPH H. SAELY, LUKAS SPRENGER, ALEXANDER VONBANK, BARBARA LARCHER, ARTHUR MADER, MAXIMILIAN MAECHLER, DANIELA PURIN, ANDREAS LEIHERER, AXEL MUENDLEIN, HEINZ DREXEL

Diabetes 2020;69(Supplement_1):412-P

DOI: https://doi.org/10.2337/db20-412-P

Published: 01 June 2020

View article

Meeting Abstracts

59-OR: Lipoprotein Particle Distribution by NMR in Youth with Type 2 Diabetes (T2D) in the TODAY Study

LORRAINE E. KATZ, JAMES D. OTVOS, KIMBERLY DREWS, BEREKET TESFALDET, FIDA BACHA, STEVEN M. WILLI, SANTICA M. MARCOVINA, SIRIPOOM MCKAY, RUTH S. WEINSTOCK

Diabetes 2020;69(Supplement_1):59-OR

DOI: https://doi.org/10.2337/db20-59-OR

Published: 01 June 2020

View article

Meeting Abstracts

580-P: Role of Bile Acids in Hepatic Lipid Metabolism: Characterization of the Fasting Lipid and Lipoprotein Profile of Tgr5-/- Hamsters

DANIELLE C.L. ALVARES, SIMON S. HOFFMAN, KHOSROW ADELI

Diabetes 2020;69(Supplement_1):580-P

DOI: https://doi.org/10.2337/db20-580-P

Published: 01 June 2020

View article

Meeting Abstracts

1437-P: A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched-Chain Amino Acids, Is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort

JOSE LUIS FLORES-GUERRERO, MARGERY A. CONNELLY, IRINA Y. SHALAUROVA, EKE G. GRUPPEN, JAMES D. OTVOS, ROBIN P.F. DULLAART, STEPHAN J.I. BAKKER

Diabetes 2020;69(Supplement_1):1437-P

DOI: https://doi.org/10.2337/db20-1437-P

Published: 01 June 2020

View article

Meeting Abstracts

1417-P: Lipoprotein(a)-Associated Residual Atherosclerotic Cardiovascular Disease Risk in Patients with Cardiovascular Disease on Statin Therapy by Diabetes Status

YANGLU ZHAO, JENNIFER C. SUNG, AURIS BROWNE, NATHAN D. WONG

Diabetes 2020;69(Supplement_1):1417-P

DOI: https://doi.org/10.2337/db20-1417-P

Published: 01 June 2020

View article

Meeting Abstracts

131-OR: GLP-1R in the Nodose Ganglion Modulate Intestinal Lipoprotein Production via a Neuroendocrine Mechanism

SIMON S. HOFFMAN, KHOSROW ADELI

Diabetes 2020;69(Supplement_1):131-OR

DOI: https://doi.org/10.2337/db20-131-OR

Published: 01 June 2020

View article

Journal Articles

Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease

Alan Chait, Henry N. Ginsberg, Tomas Vaisar, Jay W. Heinecke, Ira J. Goldberg, Karin E. Bornfeldt

Diabetes 2020;69(4):508–516

DOI: https://doi.org/10.2337/dbi19-0007

Published: 16 March 2020

View article

Meeting Abstracts

1920-P: Coingestion of Glucose and Fructose Has Synergistic Effects on Lipoprotein Risk Factors for Cardiovascular Disease in Healthy Young Adults

BETTINA HIERONIMUS, VALENTINA MEDICI, VIVIEN LEE, MARINELLE NUNEZ, PETER J. HAVEL, KIMBER L. STANHOPE

Diabetes 2019;68(Supplement_1):1920-P

DOI: https://doi.org/10.2337/db19-1920-P

Published: 01 June 2019

View article

Meeting Abstracts

23-LB: Lipoprotein Subfractions Are Associated with Diabetic Cardiovascular Disease and Death among 9,795 Patients in the FIELD Trial

STEVEN R. JONES, ALICIA J. JENKINS, ANDRZEJ S. JANUSZEWSKI, RACHEL L. OCONNELL, LIPING LI, DAVID SULLIVAN, MARJA-RIITTA TASKINEN, RUSSELL SCOTT, GERALD FRANCIS WATTS, PHILIP J. BARTER, R. JOHN SIMES, PETER P. TOTH, ANTHONY C. KEECH

Diabetes 2019;68(Supplement_1):23-LB

DOI: https://doi.org/10.2337/db19-23-LB

Published: 01 June 2019

View article

Meeting Abstracts

41-LB: Lipoprotein Subfractions Are Associated with Diabetic Microvascular Disease among 9,795 Patients in the FIELD Trial

PETER P. TOTH, ANTHONY C. KEECH, ANDRZEJ S. JANUSZEWSKI, RACHEL L. OCONNELL, LIPING LI, DAVID SULLIVAN, MARJA-RIITTA TASKINEN, PAUL L. DRURY, ESQ., GERALD FRANCIS WATTS, JAMES D. BEST, JEAN CLAUDE ANSQUER, STEVEN R. JONES, ALICIA J. JENKINS

Diabetes 2019;68(Supplement_1):41-LB

DOI: https://doi.org/10.2337/db19-41-LB

Published: 01 June 2019

View article

2 3 4 5

NARROW

404-P: Relationships among Triglyceride (TG) Concentrations across Lipoprotein Subclasses, Intraglomerular Hemodynamics, and Kidney Oxygen Availability in Adolescents with Type 1 Diabetes (T1D)

1092-P: Lipoprotein Insulin Resistance Index and Mortality in Heart Failure: A Population Study

1118-P: Prediction of Clamp-Derived Insulin Sensitivity in African Americans from Clinical Risk Factors

893-P: Triglyceride-Rich Remnant Lipoproteins, Insulin Resistance, and Subclinical Inflammation in Youth with Type 2 Diabetes

381-P: Type 2 Diabetes Significantly Modulates the Power of Lipoprotein(a) to Predict Cardiovascular Events and Mortality in Young Coronary Artery Disease Patients

300-OR: Association of Raised Lipoprotein(a) Levels with Micro- and Macrovascular Complications in Patients with Type 1 Diabetes

Simultaneous Inhibition of Peripheral CB1R and iNOS Mitigates Obesity-Related Dyslipidemia Through Distinct Mechanisms

169-OR: Differential Effects of Amount, Intensity, and Mode of Exercise Training on the Diabetes Risk Index

37-LB: GLP-2 Regulation of Dietary Fat Absorption and Intestinal Lipoprotein Production: The Role of the Enteric Nervous System via nNOS Signaling

1480-P: Increased Particle Size of Triglyceride Remnant Lipoproteins, but Not Plasma Concentration or Lipid Content, Boost Risk Prediction of Incident Type 2 Diabetes

412-P: Lipoprotein(a) and Vascular Risk in Patients with Established Cardiovascular Disease

59-OR: Lipoprotein Particle Distribution by NMR in Youth with Type 2 Diabetes (T2D) in the TODAY Study

580-P: Role of Bile Acids in Hepatic Lipid Metabolism: Characterization of the Fasting Lipid and Lipoprotein Profile of Tgr5-/- Hamsters

1437-P: A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched-Chain Amino Acids, Is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort

1417-P: Lipoprotein(a)-Associated Residual Atherosclerotic Cardiovascular Disease Risk in Patients with Cardiovascular Disease on Statin Therapy by Diabetes Status

131-OR: GLP-1R in the Nodose Ganglion Modulate Intestinal Lipoprotein Production via a Neuroendocrine Mechanism

Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease

1920-P: Coingestion of Glucose and Fructose Has Synergistic Effects on Lipoprotein Risk Factors for Cardiovascular Disease in Healthy Young Adults

23-LB: Lipoprotein Subfractions Are Associated with Diabetic Cardiovascular Disease and Death among 9,795 Patients in the FIELD Trial

41-LB: Lipoprotein Subfractions Are Associated with Diabetic Microvascular Disease among 9,795 Patients in the FIELD Trial

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only